FI920845A0 - Farmaceutiska kompositioner innehaollande interleukin-2. - Google Patents

Farmaceutiska kompositioner innehaollande interleukin-2.

Info

Publication number
FI920845A0
FI920845A0 FI920845A FI920845A FI920845A0 FI 920845 A0 FI920845 A0 FI 920845A0 FI 920845 A FI920845 A FI 920845A FI 920845 A FI920845 A FI 920845A FI 920845 A0 FI920845 A0 FI 920845A0
Authority
FI
Finland
Prior art keywords
interleukin
pharmaceutical composition
composition innehaollande
innehaollande
pharmaceutical
Prior art date
Application number
FI920845A
Other languages
English (en)
Other versions
FI920845A (fi
Inventor
Michal Schwartz
Shoshana Eitan
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of FI920845A0 publication Critical patent/FI920845A0/fi
Publication of FI920845A publication Critical patent/FI920845A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
FI920845A 1991-02-27 1992-02-26 Farmaceutiska kompositioner innehaollande interleukin-2 FI920845A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL97365A IL97365A0 (en) 1991-02-27 1991-02-27 Pharmaceutical compositions comprising a lymphokine

Publications (2)

Publication Number Publication Date
FI920845A0 true FI920845A0 (fi) 1992-02-26
FI920845A FI920845A (fi) 1992-08-28

Family

ID=11062144

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920845A FI920845A (fi) 1991-02-27 1992-02-26 Farmaceutiska kompositioner innehaollande interleukin-2

Country Status (13)

Country Link
EP (1) EP0501445A1 (fi)
JP (1) JPH05238941A (fi)
KR (1) KR920016106A (fi)
AU (1) AU647883B2 (fi)
CA (1) CA2061918A1 (fi)
FI (1) FI920845A (fi)
HU (2) HUT60437A (fi)
IE (1) IE920594A1 (fi)
IL (1) IL97365A0 (fi)
MY (1) MY131097A (fi)
NZ (1) NZ241719A (fi)
TW (1) TW208657B (fi)
ZA (1) ZA921416B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304619A (es) * 1992-07-30 1994-05-31 Yeda Res & Dev Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion.
US6267955B1 (en) 1995-09-15 2001-07-31 Yeda Research And Development Co. Ltd. Mononuclear phagocytes and their use to promote axonal regeneration
US5800812A (en) * 1995-09-15 1998-09-01 Yeda Research And Development Co. Ltd. Methods of use of mononuclear phagocytes to promote axonal regeneration
DE69740089D1 (de) 1996-03-22 2011-02-10 Stryker Corp Verfahren zur verbesserten funktionellen Erholung der motorischen Koordiination, der Sprache oder der Sinneswahrnehmung nach Trauma oder Ischämie des ZNS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
IL91459A0 (en) * 1989-08-28 1990-04-29 Yeda Res & Dev Oligodendrocyte inhibitory factor

Also Published As

Publication number Publication date
HU9303167D0 (en) 1994-01-28
AU647883B2 (en) 1994-03-31
FI920845A (fi) 1992-08-28
TW208657B (fi) 1993-07-01
CA2061918A1 (en) 1992-08-28
IL97365A0 (en) 1992-05-25
NZ241719A (en) 1994-12-22
HU9200644D0 (en) 1992-05-28
AU1126792A (en) 1992-09-03
EP0501445A1 (en) 1992-09-02
JPH05238941A (ja) 1993-09-17
ZA921416B (en) 1993-01-27
IE920594A1 (en) 1992-09-09
MY131097A (en) 2007-07-31
HUT60437A (en) 1992-09-28
KR920016106A (ko) 1992-09-24
HUT66231A (en) 1994-10-28

Similar Documents

Publication Publication Date Title
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
FI915826A0 (fi) Farmaceutiska aemnen.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
IT8920486A0 (it) Composizioni farmaceutiche.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A0 (fi) Farmaceutiska kompositioner.
MX9200622A (es) Composicion farmaceutica
UA26064A1 (uk) Фармацевтичhа композиція
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
FI923371A (fi) En farmaceutisk formulation.
FI920845A0 (fi) Farmaceutiska kompositioner innehaollande interleukin-2.
FI921786A0 (fi) Farmaceutisk foerening.
DE68907609D1 (de) Arzneimittelzusammensetzung.
FI921785A0 (fi) Farmaceutisk foerening.
DE69206398D1 (de) Reichstoffzusammensetzungen.
FI904932A (fi) Optiskt aktiva tiazetokinolin-3 -karboxylsyraderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
MX9201791A (es) Medicamentos.
MX9206975A (es) Composicion farmaceutica.

Legal Events

Date Code Title Description
FD Application lapsed